Table 1.
Murine Model | Attribute | Procedure | Main Observations | Reference |
---|---|---|---|---|
Wistar rats | Anxiety-like behavior | Oral administration of a formula—Probiotic which contained Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 | Daily subchronic doses for fourteen days has significantly reduced anxiety in rats | [231] |
BALB/c mice | Anxiety-like behavior | Daily administration of Bifidobacterium longum 1714 Bifidobacterium breve 1205, Escitalopram or vehicle | After one month and a half of treatment, both Bifidobacterium species and Escitalopram reduced anxiety, with no significant differences in corticosterone levels between groups | [232] |
Wistar rats | Anxiety-like behavior | Administration of a mixture of Lactobacillus acidophilus, Bifidobacterium lactis, and Lactobacillus fermentum | After fourteen days of treatment, the cognitive activity of stressed rats was similar to that of controls | [233] |
BALB/c mice | Depression-like behavior | Oral administration of Lactobacillus rhamnosus (JB-1) | Treatment with Lactobacillus rhamnosus (JB-1) diminished stress/anxious/depressive-related behaviors. | [234] |
Sprague-Dawley rats | Depression-like behavior | Oral administration of Bifidobacterium infantis | Treatment with Bifidobacterium infantis has an anti-depressant activity, by restoring the HPA axis function, concomitantly with a pro-inflammatory cascade decline decrease | [235] |
C57BL/6 mice | Depression-like behavior | Oral administration of Lactobacillus helveticus R0052, Lactobacillus plantarum R1012 and Bifidobacterium longum R0175, fluoxetine, or saline | Probiotic administration has diminished chronic mild stress by improving the overall immunity, followed by a significantly increase of Lactobacillus ratio | [236] |
BALC/c and Swiss Webster (SW) |
Depression-like behavior | Oral administration of fluoxetine or Lactobacillus rhamnosus JB-1 | BALB/c mice displayed a significantly antidepressant-like behavior, while SW mice did not respond to treatment | [237] |
Sprague-Dawley rats | Depression-like behavior | Oral gavage of Bifidobacterium bifidum W37, Lactobacillus brevis W63, Lactobacillus casei W56, Lactobacillus salivarius W24, Lactococcus lactis W19 and 58 or vehicle | After one month and one week, treatment significantly reduced the major depression disorder by boosting both the immune system activity and tryptophan metabolism | [238] |
Maternal immune activation mouse model | Stereotypic behaviors and vocalizations | Oral administration of Bacteroides fragilis or vehicle | Restores the social behavior after treatment; every two days for six days at weaning | [239] |